ArticleWorld journal of oncology2015

Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients.

Rashid Mir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.